We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+7.92%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$29.5B
AUM Growth
+$1.48B
(+5.3%)
Cap. Flow
-$336M
Cap. Flow
% of AUM
-1.14%
Top 10 Holdings %
Top 10 Hldgs %
25.11%
Holding
1,033
New
99
Increased
384
Reduced
375
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$488M |
| 2 |
Wabtec
WAB
|
+$200M |
| 3 |
Akamai
AKAM
|
+$154M |
| 4 |
N
Netsuite Inc
N
|
+$68.9M |
| 5 |
Under Armour
UAA
|
+$68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$490M |
| 2 |
Amazon
AMZN
|
+$144M |
| 3 |
Enovis
ENOV
|
+$116M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$106M |
| 5 |
Starbucks
SBUX
|
+$95.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.84% |
| 2 | Healthcare | 16.98% |
| 3 | Financials | 13.89% |
| 4 | Consumer Discretionary | 12.81% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLRN
226
DELISTED
Acceleron Pharma
XLRN
| $13.8M | 0.05% |
283,353
+16,370
| +6% | +$589K |
|
227
Intuit
INTU
$81.1B
| $13.7M | 0.05% |
141,978
+14,430
| +11% | +$1.4M |
|
228
Schwab US Broad Market ETF
SCHB
$42.8B
| $13.5M | 0.05% |
1,653,486
+203,298
| +14% | +$1.68M |
|
229
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $13.3M | 0.05% |
406,708
-25,297
| -6% | -$871K |
|
230
A.O. Smith
AOS
$8.38B
| $13.3M | 0.05% |
346,828
+14,492
| +4% | +$547K |
|
231
W.W. Grainger
GWW
$65.3B
| $13.2M | 0.04% |
65,174
-553
| -0.8% | -$114K |
|
232
AT&T
T
$165B
| $13.2M | 0.04% |
506,237
+7,726
| +2% | +$196K |
|
|
ENV
233
DELISTED
ENVESTNET, INC.
ENV
| $13.1M | 0.04% |
437,471
+412,026
| +1,619% | +$12.7M |
|
234
Capri Holdings
CPRI
$1.77B
| $12.9M | 0.04% |
323,244
-27,289
| -8% | -$1.12M |
|
235
Erie Indemnity
ERIE
$11.7B
| $12.9M | 0.04% |
135,165
-11,472
| -8% | -$1.04M |
|
236
Neurocrine Biosciences
NBIX
$17.7B
| $12.9M | 0.04% |
228,456
+74,902
| +49% | +$3.81M |
|
237
Illinois Tool Works
ITW
$81.4B
| $12.9M | 0.04% |
139,407
+3,789
| +3% | +$344K |
|
238
iShares Russell 2000 Growth ETF
IWO
$14.5B
| $12.8M | 0.04% |
92,202
+27,471
| +42% | +$3.9M |
|
239
Ultragenyx Pharmaceutical
RARE
$2.65B
| $12.8M | 0.04% |
114,122
+4,584
| +4% | +$458K |
|
|
RNET
240
DELISTED
RigNet, Inc.
RNET
| $12.8M | 0.04% |
617,220
-80,636
| -12% | -$2.02M |
|
|
NLSN
241
DELISTED
Nielsen Holdings plc
NLSN
| $12.7M | 0.04% |
272,427
-22,816
| -8% | -$1.07M |
|
|
DPLO
242
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $12.6M | 0.04% |
+368,773
| New | +$11.5M |
|
243
UBS Group
UBS
$170B
| $12.6M | 0.04% |
650,425
+486
| +0.1% | +$9.48K |
|
244
Global Payments
GPN
$22.1B
| $12.6M | 0.04% |
195,175
+4,323
| +2% | +$292K |
|
245
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
| $12.6M | 0.04% |
290,034
-84,599
| -23% | -$3.78M |
|
246
iShares Russell 3000 ETF
IWV
$19.5B
| $12.6M | 0.04% |
104,577
+11,507
| +12% | +$1.4M |
|
|
ASCMA
247
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $12.6M | 0.04% |
752,120
-94,267
| -11% | -$2.02M |
|
|
KG
248
Kestrel Group
KG
$71.3M
| $12.6M | 0.04% |
42,104
+1,437
| +4% | +$434K |
|
|
BXLT
249
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $12.5M | 0.04% |
321,311
+6,151
| +2% | +$214K |
|
|
ALDR
250
DELISTED
Alder Biopharmaceuticals
ALDR
| $12.5M | 0.04% |
379,579
+206,108
| +119% | +$6.97M |
|
Similar funds
QCM
Brown Advisory's Q4 2015 Portfolio in Review
As of Q4 2015, Brown Advisory held 1,033 positions worth $29.5B, up 5.3% from $28B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Brown Advisory's Q4 2015 filing shows 99 new, 384 increased, 375 reduced and 84 closed positions. Its largest new stake was Alphabet (Google) Class A: 13,188,420 shares worth $513M. The largest sale was Alphabet (Google) Class C, an estimated $490M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2015 buy was Alphabet (Google) Class A: 13,188,420 shares worth $513M.
- Brown Advisory added most to Wabtec in Q4 2015, an estimated $200M increase.
- Brown Advisory's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $490M.
- Brown Advisory fully exited CITY NATIONAL CORPORATION in Q4 2015, selling an estimated $45.1M.
- Brown Advisory's ten largest holdings make up 25% of its $29.5B portfolio in Q4 2015.
- Brown Advisory opened 99 new positions and closed 84 in Q4 2015.
- Brown Advisory's portfolio value rose 5.3% quarter-over-quarter to $29.5B.
Based on Brown Advisory's 13F filing for Q4 2015, filed 8 Feb 2016.